Metraipolis › archive › dc_e55c35cf8f75

KIT Mutation-NTRK fusion oncogenic driver switch: a novel mechanism of acquired imatinib resistance in GIST — Europe PMC PMID:41559406

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41559406
DOI
10.1038/s41698-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-11-06T15:25:43.925Z
SHA-256 of the archived text
00f504710c9fb56b0c74280a56d84e8f9b3092d9c2f6a567b06fc8fee4072cef
Stable URL of this page
https://metraipolis.com/documento/dc_e55c35cf8f75

How to cite

KIT Mutation-NTRK fusion oncogenic driver switch: a novel mechanism of acquired imatinib resistance in GIST — Europe PMC PMID:41559406 — Europe PMC (en), https://europepmc.org/article/MED/41559406 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e55c35cf8f75 (Metraipolis archive dc_e55c35cf8f75, sha256 00f504710c9fb56b0c74280a56d84e8f9b3092d9c2f6a567b06fc8fee4072cef)
BibTeX
@misc{dce55c35cf8f75,
  title = {KIT Mutation-NTRK fusion oncogenic driver switch: a novel mechanism of acquired imatinib resistance in GIST — Europe PMC PMID:41559406},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41559406},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e55c35cf8f75; sha256 00f504710c9fb56b0c74280a56d84e8f9b3092d9c2f6a567b06fc8fee4072cef},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41559406. Agents can read the archived copy with the MCP tool read_document.